Company intelligence / Profile preview

Phenotypeca

Nottingham, England, United Kingdomphenotypeca.com ↗

Ownership: Private
Development stage: Commercial

Overview

Phenotypeca has developed a proprietary QTL-based yeast breeding technology to optimize the manufacture of recombinant proteins, including vaccines, biosimilars, albumin, and cosmeceutical ingredients. Their animal-free approach aims to make biologic medicines more affordable and accessible globally. They have demonstrated expertise in cGMP environments with products approved by FDA/EU regulators but do not appear to have their own clinical-stage therapeutic assets. The company has received recognition for innovation and secured funding from major organizations like the Bill & Melinda Gates Foundation.

Therapeutic areas: OtherDermatologyInfectious Diseases
Modalities: Recombinant proteins (including albumin)BiosimilarsVaccinesPeptidesCosmeceutical ingredients
Industry: Non-Drug Biotech

Drug pipeline

2 assets

insulin glargine

Pre-clinical

Indications: Diabetes

1 more asset in the full pipeline.

Request access →

Partnerships

Bioprocessing Engineering Services (BPES) – equipment/technology partnership for bioprocessing solutions.Bill & Melinda Gates Foundation – project funding partner.

Beyond the preview

Go deeper on Phenotypeca.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phenotypeca.

Explore the full profile